Opinion

Video

Differentiating Generalized Pustular Psoriasis (GPP) from Other Skin Conditions

Dr Scott Boswell highlights how he differentiates between generalized pustular psoriasis (GPP) and other dermatologic conditions.

This is a video synopsis/summary of a panel discussion involving Tina Bhutani, MD; J. Scott Boswell, MD; and Kanya Oul, RN.

Generalized pustular psoriasis (GPP) presents in 2 main forms: with plaque psoriasis and without. Patients with plaque psoriasis can develop pustular flares, while others experience flare-ups without having plaque psoriasis in between. The latter group poses a diagnostic challenge because they may not exhibit symptoms between flare-ups, making it difficult to differentiate from other skin conditions like (acute generalized exanthematous pustulosis) AGEP, a drug eruption characterized by monomorphic sterile pustules following medication intake.

Dermatologists use biopsies to distinguish between GPP and AGEP. GPP biopsies reveal subcorneal pustules and necrotic keratinocytes, whereas AGEP biopsies show spongiosis and eosinophils. Additionally, infections like bullous impetigo and SNED can mimic GPP, but they typically lack systemic symptoms and are managed as outpatient cases.

SNED, or Wilkinson disease, particularly affects elderly females, presenting with annular pustules in body folds without systemic symptoms. These distinctions are crucial for appropriate management and treatment decisions. Biopsies play a key role in confirming the diagnosis and guiding dermatologists in distinguishing between various postural skin diseases.

Video synopsis is AI-generated and reviewed by HCPLive editorial staff.

Related Videos
Implications of Findings on Patient-Reported Outcomes for Roflumilast Foam, with Melinda Gooderham, MD
New Findings on Psoriasis Outcomes for Roflumilast Foam 0.3%, with Melinda Gooderham, MD
Methods to Manage Psoriasis Using Oral Therapies, with Andrea Murina, MD
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
Melodie Young, ASN, RN: Updates on Therapies for Pediatric Patients with Psoriasis, PsA
Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic Arthritis
Melinda Gooderham, MD: What Do the New Roflumilast Foam Data Mean for Psoriasis Patients?
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
Linda Stein Gold, MD, and Bruce Strober, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.